Thomas Frerix

Thomas Frerix

Auto-generated profile, based on publicly available information

Thomas Frerix

Google DeepMind, London, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZWZachary Wu
Zachary Wu
JAJosh Abramson
Josh Abramson
TFThomas Frerix
Thomas Frerix
ACAlexander E. Chu
Alexander E. Chu
RZRuijie K. Zhang
Ruijie K. Zhang
JWJue Wang
Jue Wang
Creating highly active enzymes for arbitrary reactions is a transformative goal for the molecular sciences 1 . Traditional protein engineering 2,3 is constrained by a reliance on existing natural starting points, which are often challenging to discover. De novo design offers the potential to overcome this by creating enzymes from first principles 4 , but has yet to achieve practically relevant catalytic properties. Here we present AlphaProtein Novo (AP Novo), a machine-learning pipeline that demonstrates, for the first time, that de novo enzyme design can outperform natural sequence mining in addressing challenging chemistry. We used AP Novo to design new-to-nature nitrene transferases to synthesise the pharmacophore piperidine with unprecedented product selectivity, and to create enzymes that degrade the environmental toxin DEHP under conditions that denature natural enzymes. We also obtained state-of-the-art catalytic efficiencies on two well-studied model reactions, and through iterative design and analysis found that key enablers of success were mechanism-inspired metrics based on AlphaFold 3 5 predictions and sequence-ensemble-based scoring of designed backbones. Our results show that de novo design has become a powerful complement to natural enzyme diversity for discovering catalysts for a range of applications.